GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (BSP:T1CH34) » Definitions » Construction In Progress

Bio-Techne (BSP:T1CH34) Construction In Progress : R$183 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Bio-Techne Construction In Progress?

Bio-Techne's quarterly construction in progress declined from Sep. 2024 (R$178 Mil) to Dec. 2024 (R$163 Mil) but then increased from Dec. 2024 (R$163 Mil) to Mar. 2025 (R$183 Mil).

Bio-Techne's annual construction in progress declined from Jun. 2022 (R$110 Mil) to Jun. 2023 (R$75 Mil) but then increased from Jun. 2023 (R$75 Mil) to Jun. 2024 (R$214 Mil).


Bio-Techne Construction In Progress Historical Data

The historical data trend for Bio-Techne's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Construction In Progress Chart

Bio-Techne Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 246.76 109.68 75.19 214.09

Bio-Techne Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 172.55 214.09 178.24 163.42 183.22

Bio-Techne Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Bio-Techne Business Description

Traded in Other Exchanges
Address
614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne Headlines

No Headlines